NCT00541073View on ClinicalTrials.gov

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

May 31, 2011

Conditions
Malignant Mesothelioma
Interventions
DIETARY_SUPPLEMENT

vitamin B12

DRUG

cisplatin

DRUG

pemetrexed disodium

GENETIC

gene expression analysis

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

Trial Locations (1)

59020

Centre Oscar Lambret, Lille

All Listed Sponsors
lead

Centre Oscar Lambret

OTHER

NCT00541073 - Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter